Search Press releases Keywords From To 9 Oct 2024 Transparency notification BlackRock, Inc. Read More 3 Oct 2024 Transparency notification BlackRock, Inc. Read More 1 Oct 2024 Transparency notification BlackRock, Inc. Read More 30 Sep 2024 Transparency notification BlackRock, Inc. Read More 30 Sep 2024 UCB announces a head-to-head study evaluating BIMZELX[®]▼(bimekizumab) versus SKYRIZI® (risankizumab) in active psoriatic arthritis Read More 27 Sep 2024 Transparency notification BlackRock, Inc. Read More Pagination First page Previous page Previous … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 … Page 20 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe